Hyperbaric Oxygen Therapy in Diabetic Foot

Plain-language summary

This study examines the effect of hyperbaric oxygen therapy in patients with diabetic foot. It included men and women aged 30-60 who had skin lesions. It was a study with no assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

National Polytechnic Institute, Mexico

Intervention

Hyperbaric oxygen therapy

Start date

1/15/2019

Estimated completion

7/15/2020

Countries

Mexico

Related genes

Locations

• Mexico City, Mexico

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

Men and women with diabetic foot and hyperbaric treatment. Ages 30-60 years. Signed informed consent form.

Exclusion Criteria:

* Patients with diabetic foot without presence of dermatologic lesions.